(Q38056842)

27 August 2017

Deregulated chromatin remodeling in the pathobiology of brain tumors (English)

1 reference

27 August 2017

Anastasia Spyropoulou

1

1 reference

27 August 2017

Christina Piperi

2

1 reference

27 August 2017

Christos Adamopoulos

3

1 reference

27 August 2017

Athanasios G Papavassiliou

4

1 reference

27 August 2017

1 March 2013

1 reference

27 August 2017

NeuroMolecular Medicine

1 reference

27 August 2017

15

1 reference

27 August 2017

1

1 reference

27 August 2017

1-24

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-012-8205-y

27 August 2017

0 references

cites work

Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Aberrant CpG island methylation of multiple genes in ependymal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

ATP-dependent nucleosome remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Chromatin proteomics and epigenetic regulatory circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Chromosomal aberrations in human neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Advances in chromatin remodeling and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Relationship between nucleosome positioning and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Non-coding RNAs, epigenetics and complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

miRNAs: Little known mediators of oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Nucleosome occupancy landscape and dynamics at mouse recombination hotspots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Copy number alterations of the polycomb gene BMI1 in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

p53 in trichostatin A induced C6 glioma cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Abrogation of mitogen-activated protein kinase and Akt signaling by vandetanib synergistically potentiates histone deacetylase inhibitor-induced apoptosis in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Global histone modification patterns as prognostic markers to classify glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Snf1--a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Radiosurgery as part of the initial management of patients with malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic silencing of PEG3 gene expression in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The DNA methylome of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase inhibitors: biology and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Interplay between different epigenetic modifications and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Molecular epigenetics and genetics in neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The genetic landscape of the childhood cancer medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Molecular diagnostics of CNS embryonal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic modifications and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Regulation of chromatin structure by site-specific histone H3 methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The multi-domain protein Np95 connects DNA methylation and histone modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Global histone modification patterns predict risk of prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Global levels of histone modifications predict prognosis in different cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Effect of valproic acid on the outcome of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Distinct methylation profiles of glioma subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Analysis of HIC-1 methylation and transcription in human ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Diversity and specialization of mammalian SWI/SNF complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Early prediction of response to Vorinostat in an orthotopic rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Identification and characterization of two novel primate-specific histone H3 variants, H3.X and H3.Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8205-Y

Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.

21 January 2018

1 reference

12 December 2020

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations

1 reference

12 December 2020

Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells

1 reference

12 December 2020

Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion

1 reference

12 December 2020

Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors

1 reference

12 December 2020

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

1 reference

12 December 2020

Epigenetic events in medulloblastoma development.

1 reference

12 December 2020

Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.

1 reference

12 December 2020

SnapShot: chromatin remodeling complexes

1 reference

12 December 2020

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors

1 reference

12 December 2020

Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage

1 reference

12 December 2020

Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment

1 reference

12 December 2020

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data

1 reference

12 December 2020

Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.

1 reference

12 December 2020

Influence of valproic acid on outcome of high-grade gliomas in children.

1 reference

12 December 2020

Genome-scale DNA methylation maps of pluripotent and differentiated cells

1 reference

12 December 2020

10.1007/S12017-012-8205-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference